MGC Pharmaceuticals Limited
MGC Pharmaceuticals Limited MXC.AX Peers
See (MXC.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MXC.AX | $0.42 | +2.44% | 18.42M | -0.13 | -$3.21 | N/A |
| CAU.AX | $0.54 | N/A | 300.53M | -16.88 | -$0.03 | N/A |
| AFP.AX | $2.37 | -3.27% | 248.53M | 23.70 | $0.10 | +0.57% |
| PBP.AX | $2.98 | -0.33% | 242.34M | 29.80 | $0.10 | +1.26% |
| LV1.AX | $0.92 | N/A | 144.06M | 3.05 | $0.30 | N/A |
| VLS.AX | $1.85 | +0.54% | 100.80M | 11.56 | $0.16 | +5.41% |
| MVP.AX | $0.60 | -3.25% | 67.03M | -1.75 | -$0.34 | N/A |
| IHL.AX | $0.04 | -10.87% | 65.07M | -0.03 | -$1.30 | N/A |
| ANP.AX | $0.06 | -4.92% | 52.29M | -2.90 | -$0.02 | N/A |
| VIT.AX | $0.07 | +5.88% | 47.68M | 7.20 | $0.01 | N/A |
Stock Comparison
MXC.AX vs CAU.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, CAU.AX has a market cap of 300.53M. Regarding current trading prices, MXC.AX is priced at $0.42, while CAU.AX trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas CAU.AX's P/E ratio is -16.88. In terms of profitability, MXC.AX's ROE is +5.63%, compared to CAU.AX's ROE of +0.34%. Regarding short-term risk, MXC.AX is less volatile compared to CAU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs AFP.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, AFP.AX has a market cap of 248.53M. Regarding current trading prices, MXC.AX is priced at $0.42, while AFP.AX trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas AFP.AX's P/E ratio is 23.70. In terms of profitability, MXC.AX's ROE is +5.63%, compared to AFP.AX's ROE of +0.14%. Regarding short-term risk, MXC.AX is more volatile compared to AFP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs PBP.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, PBP.AX has a market cap of 242.34M. Regarding current trading prices, MXC.AX is priced at $0.42, while PBP.AX trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas PBP.AX's P/E ratio is 29.80. In terms of profitability, MXC.AX's ROE is +5.63%, compared to PBP.AX's ROE of +0.13%. Regarding short-term risk, MXC.AX is more volatile compared to PBP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs LV1.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, LV1.AX has a market cap of 144.06M. Regarding current trading prices, MXC.AX is priced at $0.42, while LV1.AX trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas LV1.AX's P/E ratio is 3.05. In terms of profitability, MXC.AX's ROE is +5.63%, compared to LV1.AX's ROE of -4.96%. Regarding short-term risk, MXC.AX is more volatile compared to LV1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs VLS.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, VLS.AX has a market cap of 100.80M. Regarding current trading prices, MXC.AX is priced at $0.42, while VLS.AX trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas VLS.AX's P/E ratio is 11.56. In terms of profitability, MXC.AX's ROE is +5.63%, compared to VLS.AX's ROE of +0.17%. Regarding short-term risk, MXC.AX is more volatile compared to VLS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs MVP.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, MVP.AX has a market cap of 67.03M. Regarding current trading prices, MXC.AX is priced at $0.42, while MVP.AX trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas MVP.AX's P/E ratio is -1.75. In terms of profitability, MXC.AX's ROE is +5.63%, compared to MVP.AX's ROE of -0.59%. Regarding short-term risk, MXC.AX is less volatile compared to MVP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs IHL.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, IHL.AX has a market cap of 65.07M. Regarding current trading prices, MXC.AX is priced at $0.42, while IHL.AX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas IHL.AX's P/E ratio is -0.03. In terms of profitability, MXC.AX's ROE is +5.63%, compared to IHL.AX's ROE of -0.07%. Regarding short-term risk, MXC.AX is less volatile compared to IHL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs ANP.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, ANP.AX has a market cap of 52.29M. Regarding current trading prices, MXC.AX is priced at $0.42, while ANP.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas ANP.AX's P/E ratio is -2.90. In terms of profitability, MXC.AX's ROE is +5.63%, compared to ANP.AX's ROE of -0.73%. Regarding short-term risk, MXC.AX is less volatile compared to ANP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs VIT.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, VIT.AX has a market cap of 47.68M. Regarding current trading prices, MXC.AX is priced at $0.42, while VIT.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas VIT.AX's P/E ratio is 7.20. In terms of profitability, MXC.AX's ROE is +5.63%, compared to VIT.AX's ROE of +0.05%. Regarding short-term risk, MXC.AX is more volatile compared to VIT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs IDT.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, IDT.AX has a market cap of 44.34M. Regarding current trading prices, MXC.AX is priced at $0.42, while IDT.AX trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas IDT.AX's P/E ratio is -10.50. In terms of profitability, MXC.AX's ROE is +5.63%, compared to IDT.AX's ROE of -0.19%. Regarding short-term risk, MXC.AX is more volatile compared to IDT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs LGP.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, LGP.AX has a market cap of 34.96M. Regarding current trading prices, MXC.AX is priced at $0.42, while LGP.AX trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas LGP.AX's P/E ratio is -3.83. In terms of profitability, MXC.AX's ROE is +5.63%, compared to LGP.AX's ROE of -0.12%. Regarding short-term risk, MXC.AX is more volatile compared to LGP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs NXS.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, NXS.AX has a market cap of 27.46M. Regarding current trading prices, MXC.AX is priced at $0.42, while NXS.AX trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas NXS.AX's P/E ratio is -1.57. In terms of profitability, MXC.AX's ROE is +5.63%, compared to NXS.AX's ROE of -2.01%. Regarding short-term risk, MXC.AX is more volatile compared to NXS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs CPH.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, CPH.AX has a market cap of 23.11M. Regarding current trading prices, MXC.AX is priced at $0.42, while CPH.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas CPH.AX's P/E ratio is -0.45. In terms of profitability, MXC.AX's ROE is +5.63%, compared to CPH.AX's ROE of -1.31%. Regarding short-term risk, MXC.AX is more volatile compared to CPH.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs PXS.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, PXS.AX has a market cap of 20.23M. Regarding current trading prices, MXC.AX is priced at $0.42, while PXS.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas PXS.AX's P/E ratio is -1.40. In terms of profitability, MXC.AX's ROE is +5.63%, compared to PXS.AX's ROE of -1.43%. Regarding short-term risk, MXC.AX is more volatile compared to PXS.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs AGH.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, AGH.AX has a market cap of 19.74M. Regarding current trading prices, MXC.AX is priced at $0.42, while AGH.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas AGH.AX's P/E ratio is -0.60. In terms of profitability, MXC.AX's ROE is +5.63%, compared to AGH.AX's ROE of -51.14%. Regarding short-term risk, MXC.AX is less volatile compared to AGH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs AC8.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, AC8.AX has a market cap of 17.62M. Regarding current trading prices, MXC.AX is priced at $0.42, while AC8.AX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas AC8.AX's P/E ratio is -0.67. In terms of profitability, MXC.AX's ROE is +5.63%, compared to AC8.AX's ROE of -0.61%. Regarding short-term risk, MXC.AX is more volatile compared to AC8.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs ECS.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, ECS.AX has a market cap of 15.55M. Regarding current trading prices, MXC.AX is priced at $0.42, while ECS.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas ECS.AX's P/E ratio is N/A. In terms of profitability, MXC.AX's ROE is +5.63%, compared to ECS.AX's ROE of -0.05%. Regarding short-term risk, MXC.AX is less volatile compared to ECS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs PER.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, PER.AX has a market cap of 11.96M. Regarding current trading prices, MXC.AX is priced at $0.42, while PER.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas PER.AX's P/E ratio is -0.55. In terms of profitability, MXC.AX's ROE is +5.63%, compared to PER.AX's ROE of N/A. Regarding short-term risk, MXC.AX is less volatile compared to PER.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs HGV.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, HGV.AX has a market cap of 10.09M. Regarding current trading prices, MXC.AX is priced at $0.42, while HGV.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas HGV.AX's P/E ratio is -2.40. In terms of profitability, MXC.AX's ROE is +5.63%, compared to HGV.AX's ROE of -0.27%. Regarding short-term risk, MXC.AX is more volatile compared to HGV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs CAN.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, CAN.AX has a market cap of 9.77M. Regarding current trading prices, MXC.AX is priced at $0.42, while CAN.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas CAN.AX's P/E ratio is -0.16. In terms of profitability, MXC.AX's ROE is +5.63%, compared to CAN.AX's ROE of -4.70%. Regarding short-term risk, MXC.AX is more volatile compared to CAN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs EPN.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, EPN.AX has a market cap of 8.29M. Regarding current trading prices, MXC.AX is priced at $0.42, while EPN.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas EPN.AX's P/E ratio is -2.40. In terms of profitability, MXC.AX's ROE is +5.63%, compared to EPN.AX's ROE of -0.13%. Regarding short-term risk, MXC.AX is less volatile compared to EPN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs IVX.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, IVX.AX has a market cap of 7.52M. Regarding current trading prices, MXC.AX is priced at $0.42, while IVX.AX trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas IVX.AX's P/E ratio is -0.88. In terms of profitability, MXC.AX's ROE is +5.63%, compared to IVX.AX's ROE of -0.49%. Regarding short-term risk, MXC.AX is more volatile compared to IVX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs EOF.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, EOF.AX has a market cap of 7.33M. Regarding current trading prices, MXC.AX is priced at $0.42, while EOF.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas EOF.AX's P/E ratio is -0.50. In terms of profitability, MXC.AX's ROE is +5.63%, compared to EOF.AX's ROE of -0.51%. Regarding short-term risk, MXC.AX is less volatile compared to EOF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs CGB.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, CGB.AX has a market cap of 5.61M. Regarding current trading prices, MXC.AX is priced at $0.42, while CGB.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas CGB.AX's P/E ratio is -0.70. In terms of profitability, MXC.AX's ROE is +5.63%, compared to CGB.AX's ROE of +0.00%. Regarding short-term risk, MXC.AX is more volatile compared to CGB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs BOD.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, BOD.AX has a market cap of 4.26M. Regarding current trading prices, MXC.AX is priced at $0.42, while BOD.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas BOD.AX's P/E ratio is -0.40. In terms of profitability, MXC.AX's ROE is +5.63%, compared to BOD.AX's ROE of +0.66%. Regarding short-term risk, MXC.AX is less volatile compared to BOD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs EXL.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, EXL.AX has a market cap of 3.97M. Regarding current trading prices, MXC.AX is priced at $0.42, while EXL.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas EXL.AX's P/E ratio is -1.80. In terms of profitability, MXC.AX's ROE is +5.63%, compared to EXL.AX's ROE of -0.20%. Regarding short-term risk, MXC.AX is more volatile compared to EXL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs SCU.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, SCU.AX has a market cap of 3.85M. Regarding current trading prices, MXC.AX is priced at $0.42, while SCU.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas SCU.AX's P/E ratio is N/A. In terms of profitability, MXC.AX's ROE is +5.63%, compared to SCU.AX's ROE of -0.66%. Regarding short-term risk, MXC.AX is less volatile compared to SCU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MXC.AX.
MXC.AX vs TSN.AX Comparison
MXC.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MXC.AX stands at 18.42M. In comparison, TSN.AX has a market cap of 1.41M. Regarding current trading prices, MXC.AX is priced at $0.42, while TSN.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MXC.AX currently has a P/E ratio of -0.13, whereas TSN.AX's P/E ratio is -0.33. In terms of profitability, MXC.AX's ROE is +5.63%, compared to TSN.AX's ROE of -0.97%. Regarding short-term risk, MXC.AX is more volatile compared to TSN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MXC.AX.